Golden Ally Lifetech Group, Inc. (AQPW) Stock

About Golden Ally Lifetech Group, Inc.

Golden Ally Lifetech Group, Inc., a company in its developmental stage, concentrates on innovating across advanced technologies, energy solutions, and medical equipment. Within the bioscience and sports medicine fields, it is actively developing items like Sterilal self-sanitizing devices, PASS smart denture mouth guards, portable heart attack detection units, and melanoma screening systems. Additionally, the company provides the InCharge magnetic battery device for energy, and is making progress on graphene-based de-icing applications for the aviation industry. Founded in 2003 and headquartered in Austin, Texas, the firm was formerly known as Signet International Holdings, Inc. until it rebranded in July 2022.

Golden Ally Lifetech Group, Inc. (AQPW) stock trades at $0.00 with a market capitalization of $740856. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.37, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Golden Ally Lifetech Group, Inc. generates a return on equity (ROE) of -149.24%, return on capital employed of -374.21%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: goldenaltg.com